Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
NCT ID:
NCT03154892
Eligibility Criteria:
Inclusion Criteria:
* Patients with a diagnosis of neovascular glaucoma (Stage 1-2-3)
* Individuals who are ages 20-80 years old; male or female of chinese
* Visual acuity of light perception or better in the study eye
* Willing and able to comply with clinic visits and study-related procedures
* Provide signed informed consent
Exclusion Criteria:
* Use of intraocular anti-VEGF agents in the study eye in the past 3 months.
* Active ocular or periocular infection in the study eye
* Uncontrolled Blood Pressure
* Thromboembolism
* Congestive Heart Failure
* Renal Failure
* History of myocardial infarction
* History of Stroke
* Pregnant or breast-feeding women
* Participation in another simultaneous medical investigator or trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT03154892
Study Brief:
Protocol Section:
NCT03154892